NICE Recommends MSD’s Pembrolizumab to Treat Melanoma

By
Bob
-
0
364
The UK National Institute for Health and Care Excellence has recommended pembrolizumab, manufactured by MSD, to treat melanoma.
[Pharmaceutical Business Review (MSD)]
Press Release